Castle Biosciences (CSTL) Inventory (2018 - 2026)

Castle Biosciences has disclosed Inventory across 9 years of filings, most recently posting $10.6 million for Q2 2026.

• In Q2 2026, Inventory rose 26.46% year-over-year to $10.6 million; the TTM figure through Jun 2026 stood at $10.6 million (up 26.46% YoY), while the FY2025 annual figure was $10.3 million, up 26.05% from the prior year.
• Inventory came in at $10.6 million for Q2 2026 at Castle Biosciences, up from $10.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $10.6 million in Q2 2026 to a low of $2.4 million in Q1 2022.
• Average Inventory over 5 years is $6.9 million, with a median of $7.2 million recorded in 2024.
• Year-over-year, Inventory soared 99.55% in 2023 and dropped 10.41% in 2025.
• Over 5 years, Inventory stood at $4.0 million in 2022, then soared by 99.55% to $7.9 million in 2023, then increased by 2.43% to $8.1 million in 2024, then gained by 26.05% to $10.3 million in 2025, then climbed by 3.18% to $10.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $10.6 million in Q2 2026, $10.5 million in Q1 2026, and $10.3 million in Q4 2025.